Top

Published in:

01-03-2013 | Original Paper

Non-Injection and Injection Drug Use and STI/HIV Risk in the United States: The Degree to which Sexual Risk Behaviors Versus Sex with an STI-Infected Partner Account for Infection Transmission among Drug Users

Authors: Maria R. Khan, Amanda Berger, Jordana Hemberg, Allison O’Neill, Typhanye Penniman Dyer, Kristina Smyrk

Published in: AIDS and Behavior | Issue 3/2013

Abstract

We used the National Longitudinal Study of Adolescent Health (N = 14,322) to measure associations between non-injection crack-cocaine and injection drug use and sexually transmitted infection including HIV (STI/HIV) risk among young adults in the United States and to identify factors that mediate the relationship between drug use and infection. Respondents were categorized as injection drug users, non-injection crack-cocaine users, or non-users of crack-cocaine or injection drugs. Non-injection crack-cocaine use remained an independent correlate of STI when adjusting for age at first sex and socio-demographic characteristics (adjusted prevalence ratio (APR): 1.64, 95 % confidence interval (CI): 1.16–2.31) and sexual risk behaviors including multiple partnerships and inconsistent condom use. Injection drug use was strongly associated with STI (APR: 2.62, 95 % CI: 1.29–5.33); this association appeared to be mediated by sex with STI-infected partners rather than by sexual risk behaviors. The results underscore the importance of sexual risk reduction among all drug users including IDUs, who face high sexual as well as parenteral transmission risk.

CDC. Trends in Sexually Transmitted Diseases in the United States: 2009 National Data for Gonorrhea, Chlamydia and Syphilis Atlanta, GA: Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, 2009.

CDC. HIV Surveillance Report: Diagnoses of HIV infection and AIDS in the United States and Dependent Areas, 2009. Available at: http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/.

Celentano DD, Latimore AD, Mehta SH. Variations in sexual risks in drug users: emerging themes in a behavioral context. Curr HIV/AIDS Rep. 2008;5(4):212–8.PubMedCrossRef

Ross MW, Williams ML. Sexual behavior and illicit drug use. Annu Rev Sex Res. 2001;12:290–310.PubMed

Hwang LY, Ross MW, Zack C, Bull L, Rickman K, Holleman M. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis. 2000;31(4):920–6.PubMedCrossRef

Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58(3):219–26.PubMedCrossRef

McCoy CB, Lai S, Metsch LR, Messiah SE, Zhao W. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection. Ann Epidemiol. 2004;14(8):535–42.PubMedCrossRef

Lejuez CW, Bornovalova MA, Daughters SB, Curtin JJ. Differences in impulsivity and sexual risk behavior among inner-city crack-cocaine users and heroin users. Drug Alcohol Depend. 2005;77(2):169–75.PubMedCrossRef

Khan MR, Bolyard M, Sandoval M, et al. Social and behavioral correlates of sexually transmitted infection- and HIV-discordant sexual partnerships in Bushwick, Brooklyn, New York. J Acquir Immune Defic Syndr. 2009;51(4):470–85.PubMedCrossRef

10.

Friedman SR, Flom PL, Kottiri BJ, et al. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction. 2003;98(2):159–69.PubMedCrossRef

11.

Sena AC, Muth SQ, Heffelfinger JD, O’Dowd JO, Foust E, Leone P. Factors and the sociosexual network associated with a syphilis outbreak in rural North Carolina. Sex Transm Dis. 2007;34(5):280–7.PubMed

12.

Ellen JM, Langer LM, Zimmerman RS, Cabral RJ, Fichtner R. The link between the use of crack cocaine and the sexually transmitted diseases of a clinic population. A comparison of adolescents with adults. Sex Transm Dis. 1996;23(6):511–6.PubMedCrossRef

13.

Adimora AA, Schoenbach VJ, Martinson FE, et al. Heterosexually transmitted HIV infection among African Americans in North Carolina. J Acquir Immune Defic Syndr. 2006;41(5):616–23.PubMedCrossRef

14.

Miller M, Liao Y, Wagner M, Korves C. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex Transm Dis. 2008;35(7):696–702.PubMedCrossRef

15.

Plitt SS, Sherman SG, Strathdee SA, Taha TE. Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland. Sex Transm Infect. 2005;81(3):248–53.PubMedCrossRef

16.

Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend. 2009;101(1–2):88–91.PubMedCrossRef

17.

Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(4 Suppl 3):iii7–14.PubMed

18.

Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.PubMedCrossRef

19.

Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS. 2006;20(13):1771–5.PubMedCrossRef

20.

CDC. STD Health Equity. 2011. http://www.cdc.gov/std/health-disparities/default.htm. Accessed 28 February 2011.

21.

SAMHSA. Results from the 2009 national survey on drug use and health: volume I. Summary of national findings. Rockville, MD: Office of Applied Studies, SAMHSA, 2010.

22.

SAMHSA. The NSDUH report: injection drug use. Rockville, MD: Office of Applied Studies, SAMHSA, 2003.

23.

Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6–10.PubMedCrossRef

24.

CDC. Trends in reportable sexually transmitted diseases in the United States, 2006: National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis, 2007.

25.

Nusbaum MR, Wallace RR, Slatt LM, Kondrad EC. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus. J Am Osteopath Assoc. 2004;104(12):527–35.PubMed

26.

Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Mårdh P, editors. Sexually transmitted diseases, 3rd edn. New York: McGraw-Hill; pp. 783–809.

27.

Schulz KF, Cates W Jr, O’Mara PR. Pregnancy loss, infant death, and suffering: legacy of syphilis and gonorrhoea in Africa. Genitourin Med. 1987;63(5):320–5.PubMed

28.

Gust DA, Levine WC, St Louis ME, Braxton J, Berman SM. Mortality associated with congenital syphilis in the United States, 1992–1998. Pediatrics. 2002;109(5):E79–89.PubMedCrossRef

29.

Marai W. Lower genital tract infections among pregnant women: a review. East Afr Med J. 2001;78(11):581–5.PubMed

30.

Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med. 2004;12(4):104–7.PubMed

31.

Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.PubMedCrossRef

32.

Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(Suppl 3):5–7.PubMedCrossRef

33.

Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Trans Dis. 1992;19(2):61–77.

34.

Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349(9069):1868–73.PubMedCrossRef

35.

Bearman PS, Jones J, Udry JR. The national longitudinal study of adolescent health. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/addhealth. Accessed August 2, 2012.

36.

Udry JR. References, instruments, and questionnaires consulted in the development of the add health in-home adolescent interview. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/addhealth/data/guides/refer.pdf. Accessed August 2, 2012.

37.

Resnick MD, Bearman PS, Blum RW, et al. Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA. 1997;278(10):823–32.PubMedCrossRef

38.

Chantala K, Tabor J. Strategies to perform a design-based analysis using the add health data. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/addhealth/data/guides/weight1.pdf. Accessed August 2, 2012.

39.

Sieving RE, Beuhring T, Resnick MD, et al. Development of adolescent self-report measures from the National Longitudinal Study of Adolescent Health. J Adolesc Health. 2001;28(1):73–81.PubMedCrossRef

40.

Cohen M, Feng Q, Ford CA, et al. Biomarkers in wave III of the add health study. Carolina Population Center, The University of North Carolina at Chapel Hill. Available at: http://www.cpc.unc.edu/projects/addhealth/faqs/aboutdata/index.html/biomark.pdf. Accessed August 2, 2012.

41.

Watson EJ, Templeton A, Russell I, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol. 2002;51(12):1021–31.PubMed

42.

Johnson RE, Green TA, Schachter J, et al. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol. 2000;38(12):4382–6.PubMed

43.

Koumans EH, Johnson RE, Knapp JS, St Louis ME. Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis. 1998;27(5):1171–80.PubMedCrossRef

44.

McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940–3.PubMedCrossRef

45.

Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef

46.

Friedman SR, Bolyard M, Maslow C, Mateu-Gelabert P, Sandoval M. Harnessing the power of social networks to reduce HIV risk. Focus. 2005;20(1):5–6.PubMed

47.

Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253–62.PubMedCrossRef

48.

Gonzales R, Mooney L, Rawson RA. The methamphetamine problem in the United States. Annu Rev Public Health. 31:385–398.

49.

Shrem MT, Halkitis PN. Methamphetamine abuse in the United States: contextual, psychological and sociological considerations. J Health Psychol. 2008;13(5):669–79.PubMedCrossRef

50.

Molitor F, Truax SR, Ruiz JD, Sun RK. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998;168(2):93–7.PubMed

51.

Molitor F, Bell RA, Truax SR, Ruiz JD, Sun RK. Predictors of failure to return for HIV test result and counseling by test site type. AIDS Educ Prev. 1999;11(1):1–13.PubMed

Title: Non-Injection and Injection Drug Use and STI/HIV Risk in the United States: The Degree to which Sexual Risk Behaviors Versus Sex with an STI-Infected Partner Account for Infection Transmission among Drug Users
Authors: Maria R. Khan
Amanda Berger
Jordana Hemberg
Allison O’Neill
Typhanye Penniman Dyer
Kristina Smyrk
Publication date: 01-03-2013
Publisher: Springer US
Published in: AIDS and Behavior / Issue 3/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-012-0276-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Non-Injection and Injection Drug Use and STI/HIV Risk in the United States: The Degree to which Sexual Risk Behaviors Versus Sex with an STI-Infected Partner Account for Infection Transmission among Drug Users

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2013

Forced Sexual Initiation, Sexual Intimate Partner Violence and HIV Risk in Women: A Global Review of the Literature

HIV Prevention Interventions for Adolescents and Young Adults: What About the Needs of Gay and Bisexual Males?

Examining the Applicability of the IMB Model in Predicting Condom Use Among Sexually Active Secondary School Students in Mbarara, Uganda

Orphan Status and Time to First Sex Among Adolescents in Northern Malawi

AIDS Exceptionalism: Another Constituency Heard From

Predictors of Consistent Condom Use Among Young African American Women

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page